VueBox From Qualitative to Quantitative Analysis of linear data cross-platform compatibility.

ACIST CVi CVi minimizes the risk of contrast-induced acute kidney injury for coronary catheterizations when compared to manual injection of contrast media.

ACIST RXi Rapid Exchange FFR Systems with DPR (Diastolic Pressure Ratio), the Non-Hyperemic Index for Coronary Physiology

ACIST HDi ACIST HDi High-Definition IVUS System enables optimized visualization to inform and illuminate coronary and peripheral intervention strategy through advanced imaging modes, improved deliverability of the Kodama IVUS Catheter and interactive compact console.

The Bracco Fellowships are back 95 grants to celebrate Bracco’s 95th Anniversary

BIPSO further strengthens environmental protection BIPSO sets the course for sterile contrast media production according to the latest environmental standards.

FDA approves Gadopiclenol injection for the U.S. market Bracco Announces FDA Approval of Gadopiclenol Injection, a New Macrocyclic High-Relaxivity Gadolinium-Based Contrast Agent which will be commercialized as VUEWAY™ (gadopiclenol) injection and VUEWAY™ (gadopiclenol) Pharmacy Bulk Package by Bracco.

Empower CTA+ Efficiency and Control at your fingertips.

Contrast Induced Nephropathy Contrast Induced Nephropathy

Data protection Data Protection